Global Down Syndrome

Issue 4 of 4 2017

Issue link: https://viewer.e-digitaledition.com/i/889419

Contents of this Issue

Navigation

Page 10 of 31

SCIENCE SNPs CONTINUED ON PAGE 13 HIDRADENITIS SUPPURATIVA IN DOWN SYNDROME Hidradenitis suppurativa (HS) is a chronic skin condition driven by an exacerbated immune reaction at hair follicles that become clogged with bacteria or other substances in areas with many oil and sweat glands, such as the armpits and groin area. A recent epidemiological study surveyed for HS diagnosis in nearly 12,000 individuals with Down syndrome. The analysis revealed an approximately five- to eight-times greater risk of HS in the population with Down syndrome, as well as an earlier age of diagnosis. Thus, although only 2.1 percent of individuals with Down syndrome presented with HS, this skin condition should be added to other inflammatory skin conditions that have a higher prevalence in people with Down syndrome, such as alopecia areata and vitiligo. HS is currently treated with the anti-inflammatory drug Humira. British Journal of Dermatology, AUGUST 2017 SCREENING EARLY FOR FRAGILE BONES A study led by Dr. Angelo Carfi at the Catholic University of the Sacred Heart in Rome measured bone mineral density in 234 adults with Down syndrome between ages 20 and 69, likely the largest study of its kind to date. Using a technique called dual-energy X-ray absorptiometry, they studied bone density at the femoral neck and lumbar spine. They found that adults with Down syndrome have lower bone mineral density compared to the typical population. Importantly, the natural age-associated decline in bone density was more pronounced in people with trisomy 21. This team recommends early screening programs for osteoporosis, in both sexes, for the population with Down syndrome. Osteoporosis International, JULY 2017 POSSIBLE NEW INSIGHTS INTO THE 'WHY' OF ALZHEIMER'S DISEASE Nearly all people with Down syndrome develop the pathology of Alzheimer's disease by age 50. Researchers at the University of Massachusetts wanted to learn whether microvascular impairment, which is common in people with Alzheimer's disease, also exists in those with Down syndrome, to investigate whether such an impairment could potentially cause Alzheimer's disease. They examined brain microvasculature, which is involved in a number of neurological conditions, in five adults with Down syndrome, seven typical adults with Alzheimer's disease, and seven typical adults with healthy profiles. Microvasculature impairment in people with Down syndrome was similar to those with Alzheimer's disease, and both were significantly impaired compared to typical controls. The researchers conclude that their observations support the theory that microvasculature impairment could play a role in Alzheimer's disease and deserves further research. Alzheimer's & Dementia, JUNE 2017 MORE THAN WORDS: THE NEED TO TEACH SOCIAL LANGUAGE SKILLS Researchers from the United Kingdom and Norway investigated socially appropriate language use, also called pragmatics, in children with Down syndrome. Pragmatics includes skills such as greetings, using language suited to the correct audience or GLOBALDOWNSYNDROME.ORG 11

Articles in this issue

Links on this page

Archives of this issue

view archives of Global Down Syndrome - Issue 4 of 4 2017